title: [Serum myoglobin assay in the early phase of myocardial infarction treated with intravenous streptokinase].
authors.forename: A
authors.initials: A
authors.lastname: Grand
authors.forename: S
authors.initials: S
authors.lastname: Glaizal
authors.forename: C
authors.initials: C
authors.lastname: Caudie
authors.forename: I
authors.initials: I
authors.lastname: Schrive
authors.forename: O
authors.initials: O
authors.lastname: Matas
authors.forename: P
authors.initials: P
authors.lastname: Fichter
authors.forename: H
authors.initials: H
authors.lastname: Shibli
mesh_terms: D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy*; D009211:Myoglobin / Q000097:blood*; D013300:Streptokinase / Q000627:therapeutic use*
chemical_list: D006495:Heparin, Low-Molecular-Weight; D009211:Myoglobin; D013300:Streptokinase
vernacular_title: Dosage de la myoglobine sérique à la phase initiale d'un infarctus myocardique traité par la streptokinase intraveineuse.